INTRODUCTION
In India, direct cause of maternal mortality still remains hemorrhage. Preeclampsia, sepsis, with anemia being the most common indirect cause.
WHO has estimated that prevalence of anemia in developed and developing countries in pregnant women is 14 per cent and 51 per cent respectively. In India the prevalence of anemia is around 65-75 percent. 3 PPH is the most common cause of maternal morbidity in developing county like India and is a major cause of death.
Globally about 11% of women having live births have severe PPH amounting to 14 million women a year. 4 The incidence of PPH is said to be 3.9%in vaginal deliveries & 6.4% in cesarean deliveries. 5 In India alone, according to a review of the sample registration survey (1997) (1998) (1999) (2000) (2001) (2002) (2003) , postpartum hemorrhage accounts for nearly 38% of all maternal deaths.
Access to a safe and sufficient blood supply could help to prevent deaths of a significant number of mothers and their newborn children. India contributes to about 20% of maternal mortality in the world. Blood transfusion is associated with complications like allergic reactions (fever, anxiety, breathlessness, tachycardia, hypotension, and chest pain), acute immune hemolytic reaction, delayed hemolytic reaction, risk of transmission of viruses and infectious disease (HIV, hepatitis B & C).
Every year, millions of people are exposed to avoidable, life-threatening risks through the transfusion of unsafe blood. The first referral units were should be fully operational with expert specialist staff, infrastructure, equipment, medicines, and blood-transfusion facilities which can reduce maternal mortality.
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METHODS
Retrospective study of requirement of blood transfusion in antenatal and postnatal patients (emergency or registered) who came in labour room during last 3 months period was conducted at tertiary care unit, Ahmedabad. All antenatal and postnatal patients within peripartum period were taken.
Inclusion criteria: 1) All delivered or undelivered emergency and registered patients who came in labour room. 2) All patients requiring blood transfusion in antepartum, intrapartum and postpartum period were selected. 3) Severe anemic patients with Hb level less than 7 gm/dl were selected. 4) Postpartum patients with more than 1000 ml of blood loss were included.
RESULTS
Out of 2200 patients 440 patients required blood transfusion. In this study 70% patients required blood transfusion because of obstetric haemorrhage and 30% patients required blood because of anemia of pregnancy. 53% of patients with Hb less than 7 gm/dl required blood transfusion in present study. Major associated complications in the transfused patients were anemia (34%) and PPH (36%). In this study 82% babies were live, 12% babies were IUD and 6% babies were died in neonatal period. Out of 440 patients maternal mortality occur in 4 patients.
In this study one maternal death was occurred in multiparous vaginaly delivered woman having severe atonic PPH with poor general condition.
One patient of 2 gm/dl Hb was referred from outside died immediately after delivery due to cardiac arrest.
Two patients required many blood transfusions and blood products like FFP and PRC and developed DIC and septicemia and expired due to acute renal failure.
DISCUSSION
Because of the unpredictable nature of postpartum bleeding, blood transfusion has been identified as one of eight essential key that should be available in healthcare facilities providing comprehensive emergency obstetric care.
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In developing country two main causes of maternal mortality and morbidity regarding blood transfusion in obstetric are;
Anemia of pregnancy 2. Major obstetric haemorrhage
Anemia of pregnancy is defined as haemoglobin concentration below 11 gm/dl in first and third trimester and below 10.5 gm/dl in second trimester. Anemia is a late manifestation of iron deficiency; transfusion does not treat the cause of anemia. Preexisting anemia worsens as pregnancy advances, leading to CHF and other complication including mortality of the patient. It also impedes the patient's ability to resist infection or cop up with haemorrhage.
The decision of blood transfusion should be made on both clinical and hematological grounds. Transfusion is almost always indicated when Hb is less than 7 gm/dl 9, 10 to reduce the rate of maternal morbidity and mortality.
Obstetric haemorrhage is defined as any blood loss occurring in the peripartum period may be revealed or concealed, that is likely to endanger life. Haemorrhage is associated with 48% of direct cause of obstetric death and 38% of all maternal death. Most common obstetric emergencies in developing countries are PPH, APH, ruptured uterus, eclampsia, obstructed labour and infection.
More active participation in term of antenatal checkups and skilled management of patients at the first referral unit is advocated.
During my study blood transfusion is mainly indicated to restore red cell count in order to improve the ability of blood to transport oxygen and to prevent tissue and organ hypoxia, replacement of clotting factors, replacement of vascular volume. Blood component therapy is mainly administered to treat specific conditions like micro vascular bleeding, and coagulation factor deficiency.
Haemorrhage is extremely unpredictable so volume replacement done with up to 2 liters of crystalloid. Plasma expanders should follow until the blood is available. 15 In a case of acute bleeding, PRC was given to maintain platelet count at ≥50×109/L. Fresh frozen plasma is used for correction of hypovolemia and normalization of coagulation in a case. When DIC is strongly suspected and clotting studies take a long time, transfusion of FFP was given before result are available if haemorrhage is otherwise difficult to control.
On one side maternal morbidity and mortality depends on availability of blood and blood products, on the other side injudicious use of blood and blood products can cause infection, allergic reaction or antibody production in the mother which can have major impact on the present or future pregnancies.
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According to the World Health Organization (WHO), the four cornerstones of a safe and effective blood donor service are a national system, volunteer donations, blood testing, and avoidance of unnecessary transfusions.
12 each of these cornerstones poses challenges in developing countries, where infrastructure may be limited; the cost of blood procurement, screening, and storage is high; and blood donation is rare. In 2002, 5% to 10% of newly acquired HIV infections were related to infected blood transfusions. 13 as women and children are the most likely recipients of blood in areas of both high HIV prevalence and blood supply shortages, they are at disproportionately high risk. 14 Main purpose of this study is to make the blood available in the blood bank and should be reserved for the patients of the obstetric emergencies. Blood should be reserved for the patients of severe anemia, patients having any type of bleeding in antenatal and postnatal period.
In developing countries an understanding of public health determinants is integral to the success of any intervention to reduce maternal mortality, in addition to an understanding of the biomedical causes and management of obstetric hemorrhage. Alternatives to banked blood include autologous blood donation, normovolemic haemodilusion, and intraoperative cell salvage. These should be considered in patients who are difficult to cross match and/or who refused banked blood.
CONCLUSION
Ensuring a safe supply of blood and blood products and the appropriate and rational clinical use of blood are important public-health responsibilities of every national and state government, especially for saving lives of mothers who need comprehensive emergency obstetric care services because of pregnancy-related haemorrhage, severe anaemia, or abortions. Strategies to be make to maximize the haemoglobin (Hb) level at delivery as well as to minimize blood loss. Particular emphasis should be placed on the management of the third stage of labour, to prevent avoidable morbidities, such as PPH, retained product of conception, and vaginal lacerations, which require transfusions. Until adequate national blood banks are in place, we should continue to explore alternatives to
